GFI to acquire most of Amerex in US

GFI, the New York-based interdealer broker, has announced it will acquire the bulk of Amerex Energy’s North American operations. The deal, worth $86 million, is due to be completed before the end of October.

Amerex, based in Sugar Land, Texas, is an interdealer broker in electric power, natural gas and emissions products and related derivatives and options in North America. The parts of the company included in the acquisition had revenues of over $46 million in 2005, and exceeded $30 million in the first six months of this year.Michel Gooch, chief executive of GFI, said the move continues the company’s strategy of broadening its presence in over-the-counter energy markets, complementing other acquisitions such as the fuel broker Starsupply earlier this year. Products included in the deal include: electric power products, US federal and regional emissions products, and natural gas basis swaps, options, forwards and energy finance plans. It also encompasses various analytical and risk management services. However, the acquisition excludes Amerex’s refined products division, which will continue to operate independently under a new name.“GFI’s main clients are financial institutions and Amerex deals predominantly with the big traditional energy firms, so there is little overlap between their customer bases,” said Michelle Everaert, chief information officer at GFI.Amerex’s president, Michael Cosgrove, will continue to serve as head of the business, which has over 70 brokerage personnel based in Sugar Land.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here